FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients

BACKGROUND: Epithelial ovarian cancer (EOC) is a spectrum of different diseases, which makes their treatment a challenge. Forkhead box M1 (FOXM1) is an oncogene aberrantly expressed in many solid cancers including serous EOC, but its role in non-serous EOCs remains undefined. We examined FOXM1 expre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Exp Clin Cancer Res
Hauptverfasser: Tassi, Renata A., Todeschini, Paola, Siegel, Eric R., Calza, Stefano, Cappella, Paolo, Ardighieri, Laura, Cadei, Moris, Bugatti, Mattia, Romani, Chiara, Bandiera, Elisabetta, Zanotti, Laura, Tassone, Laura, Guarino, Donatella, Santonocito, Concetta, Capoluongo, Ettore D., Beltrame, Luca, Erba, Eugenio, Marchini, Sergio, D’Incalci, Maurizio, Donzelli, Carla, Santin, Alessandro D., Pecorelli, Sergio, Sartori, Enrico, Bignotti, Eliana, Odicino, Franco, Ravaggi, Antonella
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2017
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5422964/
https://ncbi.nlm.nih.gov/pubmed/28482906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0536-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge